Literature DB >> 12729321

Autoimmune hepatitis associated with Graves' disease.

Binglin Cui1, Masanori Abe, Satoshi Hidata, Seiji Nakanishi, Bunzo Matsuura, Kojiro Michitaka, Kazuhisa Yamamoto, Norio Horiike, Morikazu Onji.   

Abstract

A 31-year-old woman with Graves' disease with a 12-month-history of propylthiouracil intake and autoantibodies in the sera was admitted to our hospital. The differential diagnosis between autoimmune hepatitis and propylthiouracil-induced hepatitis was intractable. Steroid therapy was started and she showed a complete response to the treatment. Liver biopsy demonstrated acute hepatitis and plasma cell infiltration. A second liver biopsy, which was performed 10 months after starting steroid therapy, showed some inflammatory cells in the portal tracts. These findings suggest that she had been suffering from autoimmune hepatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729321     DOI: 10.2169/internalmedicine.42.331

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Authors:  Omar Khokhar; Christopher Gange; Stephen Clement; James Lewis
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Autoimmune cholangiopathy and high-output heart failure in a patient with graves disease.

Authors:  Deepak Venkat; Dylan Wirtz; Tushar Patel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

3.  Muscle weakness in a girl with autoimmune hepatitis and Graves' disease.

Authors:  Ahmed Sarkhy; Rabindranath Persad; Mark Tarnopolsky
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

4.  A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.

Authors:  Ikuko Sato; Taku Tsunekawa; Yuri Shinohara; Yuichiro Nishio; Yuko Shimizu; Yasuhiko Suzuki; Shuko Yoshioka
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

5.  Factors predicting abnormal liver function tests induced by Graves' disease alone: a retrospective cohort study.

Authors:  Ruiguo Zhang; Xun Tian; Lan Qin; Xiaoer Wei; Junqi Wang; Jie Shen
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.

Authors:  Renfei Wang; Jian Tan; Guizhi Zhang; Wei Zheng; Chengxia Li
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

7.  Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report.

Authors:  Mamiko Yamada; Hironori Shibata; Yohei Masugi; Tomohiro Ishi; Kaori Kameyama; Hirotoshi Ebinuma; Tomonobu Hasegawa
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

8.  Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.

Authors:  Aesha M Patel; Camille Stanback; Priyathama Vellanki
Journal:  AACE Clin Case Rep       Date:  2020-12-28

9.  Differential characteristics in drug-induced autoimmune hepatitis.

Authors:  Omar Yesid Martínez-Casas; Gabriel Sebastián Díaz-Ramírez; Juan Ignacio Marín-Zuluaga; Octavio Muñoz-Maya; Oscar Santos; Jorge Hernando Donado-Gómez; Juan Carlos Restrepo-Gutiérrez
Journal:  JGH Open       Date:  2018-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.